circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the Wnt/beta-catenin pathway
Yaming Li(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Peng Su(Qilu Hospital of Shandong University), Hanwen Zhang(Dongguan People’s Hospital), H. J. Yang(Ministry of Education of the People's Republic of China), Ying Liu(Qilu Hospital of Shandong University), Zheng Li(Qilu Hospital of Shandong University), Xiaolong Wang(Ministry of Education of the People's Republic of China), Bing Chen(Shanghai Medical College of Fudan University), Zekun Wang(WuXi AppTec (China)), Xiaojin Song(Qilu Hospital of Shandong University), Wenjing Zhao(Xinjiang Uygur Autonomous Region Product Quality Supervision and Inspection Institute), Yiran Liang(Qilu Hospital of Shandong University), Lijuan Wang(Xuzhou University of Technology), Dianwen Han(Qilu Hospital of Shandong University)
Cited by 199
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|845
Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue.
|Journal of Biological Chemistry|1993|523
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396